46
IP/PATENT TRANSACTION SYSTEM BETWEEN R&D+ INSTITUTES PROVIDING AT LEAST A BRIDGE BETWEEN US SCOPE VISION: OPENING UP IP ? IS THERE A DEMAND FOR MORE OPEN IP FROM R&D PARTNERS? IP IN MOTION DEVELOPMENTS IN IP MONETIZATION BUSINESS Dr. ir. Vincent Ryckaert, European Patent Attorney IMEC IP Business and Intelligence Director Mr. Sigrid Gilis Attorney at Law and IP Specialist

IP/PATENT TRANSACTION SYSTEM BETWEEN R&D+ INSTITUTES ... · Mr. Sigrid Gilis Attorney at Law and IP Specialist. 1984 Established by state government of Flanders in Belgium Non-profit

  • Upload
    lelien

  • View
    215

  • Download
    0

Embed Size (px)

Citation preview

IP/PATENT TRANSACTION SYSTEMBETWEEN

R&D+ INSTITUTES

PROVIDING AT LEAST A BRIDGE BETWEEN US

SCOPE VISION: OPENING UP IP ?

IS THERE A DEMAND FOR MORE OPEN IP FROM R&D PARTNERS?

IP IN MOTIONDEVELOPMENTS IN IP MONETIZATION BUSINESS

Dr. ir. Vincent Ryckaert, European Patent AttorneyIMEC IP Business and Intelligence DirectorMr. Sigrid GilisAttorney at Law and IP Specialist

2© IMEC 2012

GOAL OF THE PRESENTATION

• renew and strengthen the interest • global picture – open innovation/IP monetization

• divergence between policy and field reality• adverse effects in the market

• issues to be decided to find the right entry point• motivate by showing IMEC interest in this

(contrary on the more theoretical analysis presented last time)• present R&D life cycle model to introduce terminology• short remark to theoretical studies on IP and game theory

• most profit for most IP by non-exclusive licensing

EPIP CONFERENCELEUVEN

OPENING UP IP ?IS THERE A DEMAND FOR MORE OPEN IP FROM R&D

PARTNERS?

IP IN MOTIONRECENT INSIGHT DEVELOPMENTS IN THE IMEC IP BUSINESS

Dr. ir. Vincent Ryckaert, European Patent AttorneyIMEC IP Business and Intelligence DirectorMr. Sigrid GilisAttorney at Law and IP Specialist

1984

▸ Established by state government of Flanders in Belgium

▸ Non-profit organization

▸ Initial investment: 62m€

▸ Initial staff: ~70

2011

▸ World-leading research in nanoelectronics

▸ Revenue 2010: 285 m€ (incl. 44 m€grant from Flanders government)

▸ Staff: ~1900 worldwide

▸ Worldwide collaboration >600 companies

A. INTRODUCTION OF IMEC 1984 – 2011

5© IMEC 2012

POSITION IN THE R&D LIFE CYCLE

Providing focus for universities and basic insight and solutions for industrial partners

UniversitiesLo

nger

te

rm, m

any

optio

ns

Shor

ter

term

, ap

plic

atio

nsTim

e fr

ame

Lower HigherR&D cost

Industry

Shared R&D Platforms

6© IMEC 2012

GLOBAL R&D PLATFORMS :…TO THIS:

Providing focus for universities and basic insight and solutions for industrial partners

UniversitiesLo

nger

te

rm, m

any

optio

ns

Shor

ter

term

, ap

plic

atio

nsTim

e fr

ame

Lower HigherR&D cost

Industry

Shared R&D Platforms

Shared R&D Platforms

Shared R&D Platforms

IMEC BUSINESS PARTNERS

The World’s Largest Industry Commitment to Semiconductor Research in Partnership

LamRESEARCH

8© IMEC 2012

KEY FEATURES OF IMEC IP POLICY

1. Avoiding IP blocking for our Partners2. Securing IP Rights for our Partners3. Enabling Publications

Tools: - Use of (selective) Patenting

- Carefully designed IP model

9© IMEC 2012

IMEC IP GROUND RULES

▸ Open multi-partner model ▸ Cost & IP sharing with all Partners▸ Fairness to ecosystem ▸ Non-exclusive “use and exploitation” rights (to make/have

made, sell, offer to sell) “semiconductor” products▸ Technology Transfer via Residents (creating Results jointly with

IMEC) ▸ Co-ownership without accounting (for such jointly created

Results)▸ Access to IMEC Background ▸ Access to Material & Equipment: Normal Use clause▸ Achieves non-blocking effect for the Partners

OPEN INNOVATION In-ward: Universities (PhD’s > 200 persons)In-ward: Industry (Suppliers – in-kind – equipment/materials/software/IP blocks)In-ward: Industry (Industrial Residents >300 persons)Outward: Industry

IMEC Industrial Affiliation ProgramsDevelopment on Demand Low volume prototypingTechnology TransferSpin-offIP monetization

Outward: Alliances

To be worked at: IP in – from Academia/Industry –in a structured manner

WHO IS DEMANDING MORE OPEN IP ?

Industrial partners- shift to later life cycle

Academia- focus on spin-off

Government- more KPIs

Internal- justified?

12© IMEC 2012

INDUSTRIAL PARTNERS – SHIFT TO LATER LIFE CYCLE

▸Governmental Funded - Fundamental Research: no industry

- Basic Research Funded projects: no industry

- Applied Research Projects: industry involvement and no industry financing

- Applied Research Projects: industry involvement and co-funding

▸Bilateral- Consortia, programs

- Bilateral R&D

- Development on Demand

- Low Volume Manufacturing

- Transfer and/or IP Licensing and/or Spin-off Creation

- IP Monetization

13© IMEC 2012

ACADEMIA– FOCUS ON SPIN-OFF▸Governmental Funded

- Fundamental Research: no industry

- Basic Research Funded projects: no industry

-----------------------------------------------------------------------------------------------

- Applied Research Projects: industry involvement and no industry financing

- Applied Research Projects: industry involvement and co-funding

▸Bilateral- Consortia, programs (cost sharing)

-----------------------------------------------------------------------------------------------

- Bilateral R&D

- Development on Demand

- Low Volume Manufacturing

- Transfer and/or IP Licensing and/or Spin-off Creation

- IP monetization

A B

14© IMEC 2012

GOVERNMENT – DEMANDS GROWTH OF PATENT PORTFOLIO

15© IMEC 2012

GOVERNMENT – DEMANDS GROWTH OF PATENT PORTFOLIO

• ~120 filings/year

16© IMEC 2012

INTERNAL REQUEST FOR OPENING UP IP?What is openness? (open innovation, open source, open access)

Openness: - trade secrets – hardly used- publishing “yes” (in combination with patents)- talking without NDA

• not an issue for selected info• over use of NDAs not requested by IP

- sharing of material “yes” – see standard evaluation agreements

Questions to ask:- is the info you are open about really yours (and only yours)?- any confidentiality restrictions? (hitting liabilities)?- what is the value proposition left for paying partners?

17© IMEC 2012

IMEC – MORE OPEN?

The wrong question? - ARE WE NOT THE NON-EXCLUSIVE CHAMPIONS ALREADY?

The wrong message!- MIGHT WE NOT BE HIT WITH LIABILITIES BECAUSE WE INTRODUCE

SLOPPINESS?

Can we decide on this?- WHAT DO OUR PARTNERS DICTATE?

• Industry NO

• Academia NO

• Government NO

• Internal YES – BUT DANGEROUS

ANYTHING TO GAIN? (or to loose – how are we perceived externally?)

18© IMEC 2012

CONCLUSIONS ON IMEC – OPEN

IMEC seems to be known for its NON-EXCLUSIVE IP MODEL IN INDUSTRY (for some industry partners too much)

on UNIVERSITY SIDE, the IMEC MODEL OF NON-EXCLUSIVE DEAL MAKING is NOT HEAVILY APPRECIATED

IMEC is engaging in the more competitive field and models for extracting IP VALUE – OPENNESS (if wrongly perceived) are CONTRADICTORY thereto

IMEC is promoting NON-BLOCKING approaches for the IP market (policy-wise, PATENT POOLS) - but FULL OPENNESS seems RATHER NEGATIVE PERCIEVED in such context

IMEC also promoted that UNREASONABLE IP DILUTION in the early state is rather HAMPERING technology entry in the market and defined lots of intermediate approaches

so who is asking this? NOT OUR (paying) PARTNERS IN INDUSTRY, NOT OUR UNIVERSITY NETWORK, INTERNAL ONLY, WHY?

19© IMEC 2012

IP IN MOTION - IP MONETIZATION Sale of `old’ patents – financial demand

some successesnew offerings outNew offerings in preparation

Considerations1. Securing our eco-system and risk management – cold feet- value versus risks/liabilities// parties to consider - which intermediaries to select //cost versus risks/liabilities

2. Business practice policy --- still struggling with- avoiding submarine type approach - Pre-offering to IMEC partners?

3. Why is IP market booming? Failure of Early Stage IP market

• Overemphasize on spin-off creation• Lack of trust between R&D players

20© IMEC 2012

IP IN MOTION - IP BUSINESS IN EU R&D SCENE

1. None

2. BG licensing (exclusions?)

3. Joint IP – minor

4. Joint IP – highly debated in CA negotiations▸ Emphasize on mutual blocking

21© IMEC 2012

IP PROPOSALS FOR TTO CIRCLE1. Create IP business frame work for early

stage IP▸ Focus on patents (clearly identified IP) first▸ Respecting each other business autonomy – no

joint business▸ Adapted financial consideration ▸ Simple predetermined (parameterized) scheme

2. Apply such IP business frame in collaborations

▸ In funded projects▸ Especially on joint IP

22© IMEC 2012

SITUATION TODAY

• Scope patents or broader• Might open difficult issues on improvement IP

• Scope BG program licenses or broader• Seems to fit the R&D life cycle model

• Soft-co-management versus steered actions

• Voluntary or obligations

• Support

• Mediation

• Evaluation

• Evolutionary

23© IMEC 2012

GLOBAL R&D PLATFORMS: GOING FROM THIS…

Providing focus for universities and basic insight and solutions for industrial partners

UniversitiesLo

nger

te

rm, m

any

optio

ns

Shor

ter

term

, ap

plic

atio

nsTim

e fr

ame

Lower HigherR&D cost

Industry

Shared R&D Platforms

24© IMEC 2012

GLOBAL R&D PLATFORMS :…TO THIS:

Providing focus for universities and basic insight and solutions for industrial partners

UniversitiesLo

nger

te

rm, m

any

optio

ns

Shor

ter

term

, ap

plic

atio

nsTim

e fr

ame

Lower HigherR&D cost

Industry

Shared R&D Platforms

Shared R&D Platforms

Shared R&D Platforms

25© IMEC 2012

CONCLUSIONS1. IMEC IP model – more dynamic than ever before▸ Broader license scope makes sense

2. IMEC recognizing and starting to use the IP market evolutions – but caution on policy side

▸ We`d better create our own early life cycle IP market

3. IMEC experience a less open field environment

4. IMEC believes it is time to discuss IP in- and out-licensing with other EU research institutes

1. To overcome failure of early stage IP market2. To overcome adverse effects of EOL IP monetization3. To create true EU collaboration

5. IMEC willing to bring its experience with Academia on the table to achieve concrete solutions

Work Package 1

Facilitate R&D collaboration and

increase the use of research results

Dr. ir. Vincent Ryckaert, IMECDr. Olivier Eulaerts, JRC

EARLY(IER) STAGE IPR TRANSACTIONS BETWEEN R&D ACTORS

AN OPPORTUNITY TO STRENGTHEN INNOVATION IN EU?

IPR TRANSACTIONS

INDUSTRYIP/Knowledge 

Creation

INDUSTRYIP/Knowledge 

Creation

Secondary IP market

Cross‐licensing

ProductsServices

ProductsServices

Licensing-out/Selling-out

Secondary IP market

MARKET

Licensing‐in/Buy‐in

IPR TRANSACTIONS

INDUSTRYIP/Knowledge 

Creation

INDUSTRYIP/Knowledge 

Creation

Secondary IP market

Licensing‐out/Selling‐out

Licensing‐in/Buy‐in

Cross‐licensing

PROIP/Knowledge 

Creation

PROIP/Knowledge 

Creation

ProductsServices

Licensingout

ProductsServices

Spin‐off Companies Contract Research 

Services

Licensingout

Spin‐off Companies Contract Research 

ServicesSecondary IP market

MARKET

No acquisition

No cross‐licensing (FTO)

No licensing

IPR TRANSACTIONS BETWEEN PROS

Why is this not happening?

Emotional factorsNot invented here syndromother PRO’s IP is unknown, we feel we are competitors (but are we really?)Trust issue (difficulty to leave another PRO to negotiate alone)Fear of change Risky aventure (lack of previous experience)

Narrow perspectiveNo short term effectunderestimated potentialduty to maximise the use of IP portfolios

Technical aspectsInsufficient portfolio management

IPR TRANSACTIONS BETWEEN PROS

Why should it happen?

Innovation is the only engine behind Europe’s capacity to sustain its economic and societal model

Europe invests heavily in Research, but performs less when transforming research into innovations

IP portfolios of PROs are under‐used and ways to bring more IP to the market should be explored

PROs are collaborating in R&D projects but rarely exploit jointly the complementary IPRs generated

The present conservative stance is unproductive and lead PROs toeither drop IP or sell IP on secondary IP markets

A framework should be created to facilitate IPR transactions between PROs

How to make it happen?

Start small, on a voluntary basis

Start with Patents, then tangible Know‐How (e.g. software), then knowledge

Start with some demonstration as model e.g. on joint IP in funded projects

KISS ‐ Keep it simple and standardised (model/standard agreements)

K it fl ibl bi ti f d bil t l t

IPR TRANSACTIONS Between PROs

STATUS AND NEXT STEPS

Work Package 1

WHAT HAS BEEN DONE SO FAR

WP1 timeline 

Grenoble Mtg1st brainstorming

October 2011  January 2012

Survey on 9 Work Packages

March 2012

Brainstorming in Brussels on WP1

April 2012

Rome MtgCreation Working Group on WP1

(WGWP1)

WP1 Aim to enhance the operations of the TTOs of the partner organisations by 

‐ reducing barriers to collaboration, ‐ fostering the use of IP assets and know‐how, ‐ increasing interactions with industry and SMEs. The underlying goal is.‐ exploring synergies with other work packages of the Circle

35© IMEC 2012

WORKING GROUP ON WP1

Proposal for Mandate‐ To explore concrete ways to increase the use (both by Market and PROs) of the IPR and know‐how generated by the partners of the TTO Circle + to propose implementation plan.‐To report to the next plenary meeting. 

Proposal for Composition1 representative from 3 to 5 partner organisations and 1 representative from the Secretariat of the network. 

Boundary conditions‐ Partners shall remain owners of their IPR.‐ Participation to the adopted initiatives will not be compulsory.‐ Participation will be modular i.e. each organisation can participate to selected initiatives.‐ Others?

36© IMEC 2012

WORKING GROUP ON WP1

Dimensions to explore

PROIP/Knowledge 

Creation

PROIP/Knowledge 

Creation

Freedom‐to‐operateCommon principles for IP in 

joint R&D

IP mediation mechanism

IPR bundling

Non‐exclusive use of IPR

Exchange and use of Know‐How

Others

37© IMEC 2012

CREATION OF A PATENT POOL

Purpose: sharing of existing technology and collaboration – create mutual gains

Initial iniative: creation of a Patent Co-Management platform/environment; this is a closed circuit for participating parties on a voluntary basis; royalty based; restricted to patents, predetermined to Background; with sublicensing scheme; co-management = cost sharing + option scheme…..

* valuation system: fixed fee determined in advance by the offering party

38© IMEC 2012

IMEC: CO-MANAGEMENT SYSTEM

* engaging parties: proposer/ Offering Party –interested/ Receiving party

* option = cost share = proposed 25% but free to set a % yourself; option fee = % fee of the cost

* communicate the fee if the engager exercise the option for a background license: now fixed fee

* predetermined character on the prices

* proposer fixes the prices = fee per year

39© IMEC 2012

PURPOSE - IMEC * Important for research programs in our R&D life cycle

* frame: free flow, less controlled

* intermediate position might be support

*starting with a simple basic model in order to rework the basic system on a gradual basis = start with a practical, fix and clear frame which can be adapted and expandend afterwards

* diminish consortium agreements,…

* light version

* exploration of an IP-dealing system

40© IMEC 2012

SCOPE - IMEC * patents

* background licenses to start with: simple approach: licensing of BG, no know-how transfer or sael of patents; work with a frame that contains bare minimum = code of conduct

* entering the patent pool and participation does not imply a prior offering

* set up a code of conduct or regulation for engaging parties which can participate in the patent pool as a proposer or interested party at the sime time, while acting according to guidelines and resepcting contractual freedom

41© IMEC 2012

TTO COLLABORATION AGREEMENT

* broader scope: know-how; softare, materials, equipment, patents, …

* immediately a moderated and more complex scheme

* more incumbrances/issues: what with creation of new IP blocking

*

42© IMEC 2012

TTO: CONSORTIUM AGREEMENT Four main elements:

1. access rights for R&D: internal research with possibility 3rd parties

2. Collaboration

3. Contract R&D=closer to the market

4. Exploitation

System: you need to offer to participate

Option = linked with Evaluation scheme

43© IMEC 2012

TTO

* Broadening of IP aspects… (vertically)

* Broadening horizontally in R&D lifecycle:

- sublicenses are linked/intertwined with FG,

- pay for commercial use = ok

- free for internal use and research program = ok

- in between: intermediate phase needs to be taken into account

* controlled system/ forced system

44© IMEC 2012

TNO: PRACTICALITIES

45© IMEC 2012

TNO: PRACTICALITIES * valuation of patents?

*determining a minimum fee might be a hard burden on the Proposer how to assess a patent valuation?

* limited scope to non-exclusive Bglicenses

* IT-concept? Database/platform? How to make the system operational?

* continue feedback/control: assign a manager/coördinator/intermediary/mediator

* evaluation system

* anti-blocking

46© IMEC 2012

WORKING GROUP ON WP1

Discussion